196 related articles for article (PubMed ID: 19766654)
1. Identification of a function-specific mutation of clathrin heavy chain (CHC) required for p53 transactivation.
Ohata H; Ota N; Shirouzu M; Yokoyama S; Yokota J; Taya Y; Enari M
J Mol Biol; 2009 Dec; 394(3):460-71. PubMed ID: 19766654
[TBL] [Abstract][Full Text] [Related]
2. Regulation of clathrin-mediated endocytosis by p53.
Endo Y; Sugiyama A; Li SA; Ohmori K; Ohata H; Yoshida Y; Shibuya M; Takei K; Enari M; Taya Y
Genes Cells; 2008 Apr; 13(4):375-86. PubMed ID: 18363968
[TBL] [Abstract][Full Text] [Related]
3. Monomeric but not trimeric clathrin heavy chain regulates p53-mediated transcription.
Ohmori K; Endo Y; Yoshida Y; Ohata H; Taya Y; Enari M
Oncogene; 2008 Apr; 27(15):2215-27. PubMed ID: 17952123
[TBL] [Abstract][Full Text] [Related]
4. Requirement of clathrin heavy chain for p53-mediated transcription.
Enari M; Ohmori K; Kitabayashi I; Taya Y
Genes Dev; 2006 May; 20(9):1087-99. PubMed ID: 16618797
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
6. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.
Gostissa M; Hengstermann A; Fogal V; Sandy P; Schwarz SE; Scheffner M; Del Sal G
EMBO J; 1999 Nov; 18(22):6462-71. PubMed ID: 10562558
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of clathrin heavy chain in Drosophila melanogaster.
Wingen C; Stümpges B; Hoch M; Behr M
Gene Expr Patterns; 2009 Oct; 9(7):549-54. PubMed ID: 19577664
[TBL] [Abstract][Full Text] [Related]
8. Identification of clathrin heavy chain as a direct interaction partner for the gamma-aminobutyric acid type A receptor associated protein.
Mohrlüder J; Hoffmann Y; Stangler T; Hänel K; Willbold D
Biochemistry; 2007 Dec; 46(50):14537-43. PubMed ID: 18027972
[TBL] [Abstract][Full Text] [Related]
9. Notch down-regulation by endocytosis is essential for pigment cell determination and survival in the Drosophila retina.
Peralta S; Gómez Y; González-Gaitán MA; Moya F; Vinós J
Mech Dev; 2009; 126(3-4):256-69. PubMed ID: 19027066
[TBL] [Abstract][Full Text] [Related]
10. Structure and functionality of a designed p53 dimer.
Davison TS; Nie X; Ma W; Lin Y; Kay C; Benchimol S; Arrowsmith CH
J Mol Biol; 2001 Mar; 307(2):605-17. PubMed ID: 11254385
[TBL] [Abstract][Full Text] [Related]
11. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.
Lubin DJ; Butler JS; Loh SN
J Mol Biol; 2010 Jan; 395(4):705-16. PubMed ID: 19913028
[TBL] [Abstract][Full Text] [Related]
12. Activation of NFAT signal by p53-K120R mutant.
Shinmen N; Koshida T; Kumazawa T; Sato K; Shimada H; Matsutani T; Iwadate Y; Takiguchi M; Hiwasa T
FEBS Lett; 2009 Jun; 583(12):1916-22. PubMed ID: 19416725
[TBL] [Abstract][Full Text] [Related]
13. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells.
Sun X; Yau VK; Briggs BJ; Whittaker GR
Virology; 2005 Jul; 338(1):53-60. PubMed ID: 15936793
[TBL] [Abstract][Full Text] [Related]
14. Synaptotagmin I binds intestinal epithelial NHE3 and mediates cAMP- and Ca2+-induced endocytosis by recruitment of AP2 and clathrin.
Musch MW; Arvans DL; Walsh-Reitz MM; Uchiyama K; Fukuda M; Chang EB
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1549-58. PubMed ID: 17307723
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
16. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning.
Golubovskaya VM; Finch R; Zheng M; Kurenova EV; Cance WG
Biochem J; 2008 Apr; 411(1):151-60. PubMed ID: 18215142
[TBL] [Abstract][Full Text] [Related]
17. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay.
Maurici D; Monti P; Campomenosi P; North S; Frebourg T; Fronza G; Hainaut P
Oncogene; 2001 Jun; 20(27):3533-40. PubMed ID: 11429700
[TBL] [Abstract][Full Text] [Related]
18. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Kato S; Han SY; Liu W; Otsuka K; Shibata H; Kanamaru R; Ishioka C
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8424-9. PubMed ID: 12826609
[TBL] [Abstract][Full Text] [Related]
19. [Construction of chimeric tumor suppressor p53 resistant to the dominant-negative interaction with p53 mutants].
Almazov VP; Morgunkova AA; Kalinin VN; Kopnin BP; Prasolov VS; Chumakov PM
Mol Biol (Mosk); 2002; 36(4):664-71. PubMed ID: 12173471
[TBL] [Abstract][Full Text] [Related]
20. Structural differences in the DNA binding domains of human p53 and its C. elegans ortholog Cep-1.
Huyen Y; Jeffrey PD; Derry WB; Rothman JH; Pavletich NP; Stavridi ES; Halazonetis TD
Structure; 2004 Jul; 12(7):1237-43. PubMed ID: 15242600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
